Christopher Causey, Director at UNITED THERAPEUTICS Corp (UTHR), sold 5,983 shares at $226.72 ($1.3M) on 2022-05-26, disclosed to the SEC on 2022-05-26.
Seasonal sale ($1.3M) by Director — this insider has traded UTHR in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $221.65 | 700 | $155K | 11.6% |
| 2 | $222.96 | 2,600 | $580K | 43.3% |
| 3 | $224.10 | 983 | $220K | 16.5% |
| 4 | $224.10 | 983 | $220K | 16.5% |
| 5 | $226.06 | 167 | $38K | 2.8% |
| 6 | $226.72 | 350 |
| $79K |
| 5.9% |
| 7 | $227.44 | 200 | $45K | 3.4% |
| Total | $223.64 avg | 5,983 | $1.3M | 100% |
| Filing → |
| UTHR | SELL | 2026-02-25 | $520K | — | Filing → |
| UTHR | SELL | 2026-01-06 | $510K | — | Filing → |
| UTHR | SELL | 2026-01-05 | $500K | — | Filing → |